Skip to main content

Table 1 Main statistical parameters of the trial calculation

From: The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

Parameter  
p0 10%
p1 30%
α 5%
β 10%
Number of patients  
Stage I 18
Stage II 17
Rejection of therapy  
Stage I 0 - 2 responder among 18 patients
Stage II 0 - 6 responder among 35 patients